Does hormone replacement therapy affect the use of prescription medicines in postmenopausal women: Experience from the Estonian postmenopausal hormone therapy trial [ISRCTN35338757]

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 114, Issue 5, 2007, Pages 548-554

  Veerus, P ^a,b,c   Fischer, K ^d   Hovi, S L ^c,e   Karro, H ^f   Hemminki, E ^e  

^a NATIONAL INSTITUTE FOR HEALTH DEVELOPMENT   (Estonia)

^b Estonian Centre of Excellence in Behavioural and Health Sciences   (Estonia)

^c UNIVERSITY OF TAMPERE   (Finland)

^d UNIVERSITY OF TARTU   (Estonia)

^e NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^f TARTU UNIVERSITY HOSPITAL   (Estonia)

Author keywords

Hormone replacement therapy; Prescription medication; Randomised controlled trial

Indexed keywords

ANTACID AGENT; ANTIALLERGIC AGENT; ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTIMIGRAINE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM CHANNEL BLOCKING AGENT; CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; DIURETIC AGENT; HYPNOTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL ANTIDIABETIC AGENT; PLACEBO; SEDATIVE AGENT; SEROTONIN UPTAKE INHIBITOR; THYROID HORMONE;

ADULT; ANGINA PECTORIS; ARTICLE; BODY MASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG USE; ELECTRONIC MEDICAL RECORD; ESTROGEN THERAPY; FEMALE; FOLLOW UP; HAZARD ASSESSMENT; HEART ARRHYTHMIA; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; MATERNAL AGE; MEDICAL RECORD; POSTMENOPAUSE; PRESCRIPTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SAMPLE SIZE; SOCIOECONOMICS; UNEMPLOYMENT; VAGINA CANDIDIASIS; VAGINITIS; VULVITIS;

DOUBLE-BLIND METHOD; DRUG THERAPY; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; MIDDLE AGED; POSTMENOPAUSE; PRESCRIPTIONS, DRUG; PROGNOSIS;

EID: 34247099374     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2007.01292.x     Document Type: Article

References (29)

1. Small R, Friedman GD, Ettinger B. Concomitant medication use in postmenopausal women using estrogen therapy. Menopause 2001;8:120-6.
2. Jacobs PA, Hyland ME. An evaluation of the benefits of taking hormone replacement therapy with other prescription drugs. Maturitas 2003;46:273-81.
3. Khatibi EA, Samsioe G, Li C, Lidfeldbt J, Agardh CD, Nerbrand C. Does hormone replacement therapy increase allergic reactions and upper gastrointestinal problems? Results form a population-based study of Swedish woman. The women's health in the Lund area (WHILA) study. Maturitas 2004;48:438-45.
4. Thorp JM, Gavin NI, Ohsfeldt RL. Hormone replacement therapy in postmenopausal women: utilization of health care resources by new users. Am J Obstet Gynecol 2001;185:318-26.
5. McIntyre RS, Konarski JZ, Grigoriadis S, Fan NC, Mancini DA, Fulton KA, et al. Hormone replacement therapy and antidepressant prescription patterns: a reciprocal relationship. CMAJ 2005;172:57-59.
6. Lawlor DA, Davey Smith G, Bruckdorfer KR, Kundu D, Ebrahim S. Those confounded vitamins: what can we learn from the differences between observational versus randomised trial evidence? Lancet 2004;363:1724-7.
7. Furberg CD, Vittinghoff E, Davidson M, Herrington DM, Simon JA, Wenger NK, et al. Subgroup interactions in the Heart and Estrogen/Progestin Replacement Study. Lessons learned. Circulation 2002;105:917-22.
8. Hays J, Hunt JR, Hubbell FA, Anderson GL, Limacher M, Allen C, et al. The Women's Health Initiative Recruitment Methods and Results. Ann Epidemiol 2003;13:S18-S77.
9. Veerus P, Fischer K, Hovi SL, Hakama M, Rahu M, Hemminki E. Postmenopausal hormone therapy increases use of health services: experience from the Estonian Postmenopausal Hormone Therapy Trial [ISRCTN35338757]. Am J Obstet Gynecol 2006;195:62-71.
10. Hemminki E, Hovi SL, Veerus P, Sevon T, Tuimala R, Rahu M, et al. Blinding decreased recruitment in a prevention trial of postmenopausal hormone therapy. J Clin Epidemiol 2004;57:1237-43.
11. Vorobjov S, Hovi SL, Veerus P, Pisarev H, Rahu M, Hemminki E. Treatment adherence in the Estonian Postmenopausal Hormone Therapy (EPHT) trial [ISRCTN35338757]. Maturitas 2005;52:286-95.
12. Barrett-Connor E, Grady D, Stefanick ML. The rise and fall of menopausal hormone therapy. Annu Rev Public Health 2005;26:115-40.
13. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-33.
14. WHO Collaborating Centre for Drugs Statistics Methodology. ATC/DDD Index 2005 [http://www.whocc.no/atcddd/]. Accessed 12 September 2005.
15. Estonian Health Insurance Fund [http://www.haigekassa.ee/eng/]. Accessed 10 May 2005.
16. International Statistical Classification of Diseases and Related Health Problems, 1989 Revision. Geneva: World Health Organization, 1992.
17. The R Project for Statistical Computing [http://www.r-project.org]. Accessed 31 August 2005.
18. Hickey M, Davis SR, Sturdee DW. Treatment of menopausal symptoms: what shall we do now? Lancet 2005;366:409-21.
19. Antonijevic IA. Depressive disorders - is it time to endorse different pathophysiologies? Psychoneuroendocrinology 2006;31:16-22.
20. Rodstrom K, Bengtsson C, Lissner L, Milsom I, Sundh V, Bjorkelund C. A longitudinal study of the treatment of hot flushes: the population study of women in Gothenburg during a quarter of a century. Menopause 2002;9:151-2.
21. Muntwyler J, Follath F. Calcium channel blockers in treatment for hypertension. Prog Cardiovasc Dis 2001;44:207-16.
22. Mueck AO, Seeger H. Effect of hormone therapy on blood pressure in normotensive and hypertensive postmenopausal women. Maturitas 2004;49:189-203.
23. Karalis I, Beevers G, Beevers M, Lip G. Hormone replacement therapy and arterial blood pressure in postmenopausal women with hypertension. Blood Press 2005;14:38-44.
24. Devillard E, Burton JP, Hammond JA, Lam D, Reid G. Novel insight into the vaginal microflora in postmenopausal women under hormone replacement therapy as analyzed by PCR-denaturing gradient gel electrophoresis. Eur J Obstet Gynecol Reprod Biol 2004;117:76-81.
25. Pabich WL, Fihn SD, Stamm WE, Scholes D, Boyko EJ, Gupta K. Prevalence and determinants of vaginal flora alterations in postmenopausal women. J Infect Dis 2003;188:1054-8.
26. Palacios S, Castelo-Branco C, Cancelo MJ, Vazquez F. Low-dose, vaginally administered estrogens may enhance local benefits of systemic therapy in the treatment of urogenital atrophy in postmenopausal women on hormone therapy. Maturitas 2005;50:98-104.
27. Cotterchio M, Kreiger N, Darlington G, Steingart A. Comparison of self-reported and physician-reported antidepressant medication use. Ann Epidemiol 1999;9:283-9.
28. Kuhl H. Pharmacology of estrogens and progestogens: influence of different routes of administration. Climacteric 2005;Suppl 1:3-63.
29. Gross CP, Garg PP, Krumholz HM. The generalizability of observational data to elderly patients was dependent on the research question in a systemic review. J Clin Epidemiol 2005;58:130-7.